Novel biomarkers and indicators in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study

被引：0
|
作者：
Huang, L. [1 ,2 ]
Li, L. [1 ,3 ]
Hu, E. C. [1 ,2 ]
Chen, G. [1 ,2 ]
Meng, X. M. [1 ,4 ]
Xiong, C. M. [1 ,2 ]
He, J. G. [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll, Ctr Pulm Vasc Dis, Beijing, Peoples R China
[3] Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China
[4] Peking Union Med Coll, Cent Lab, Beijing, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4532
引用
收藏
页码：953 / 953
页数：1
相关论文
共 50 条
  • [1] Potential biomarkers and targets in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study
    Huang, Li
    Li, Li
    Hu, Enci
    Chen, Guo
    Meng, Xianmin
    Xiong, Changming
    He, Jianguo
    [J]. PULMONARY CIRCULATION, 2018, 8 (02)
  • [2] Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease
    Smadja, David M.
    Gaussem, Pascale
    Mauge, Laetitia
    Lacroix, Romaric
    Gandrille, Sophie
    Remones, Veronique
    Peyrard, Severine
    Sabatier, Florence
    Bonnet, Damien
    Levy, Marilyne
    [J]. PEDIATRIC CARDIOLOGY, 2010, 31 (05) : 657 - 662
  • [3] Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease
    David M. Smadja
    Pascale Gaussem
    Laetitia Mauge
    Romaric Lacroix
    Sophie Gandrille
    Véronique Remones
    Séverine Peyrard
    Florence Sabatier
    Damien Bonnet
    Marilyne Lévy
    [J]. Pediatric Cardiology, 2010, 31 : 657 - 662
  • [4] Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
    Huang, Li
    Li, Li
    Yang, Tao
    Li, Wen
    Song, Li
    Meng, Xianmin
    Gu, Qing
    Xiong, Changming
    He, Jianguo
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (12) : 6249 - 6261
  • [5] Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease
    Egito, EST
    Aiello, VD
    Bosisio, IBJ
    Lichtenfels, AJ
    Horta, ALM
    Saldiva, PHN
    Capelozzi, VL
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (08) : 521 - 532
  • [6] Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease
    van der Feen, Diederik E.
    Bartelds, Beatrijs
    de Boer, Rudolf A.
    Berger, Rolf M. F.
    [J]. HEART, 2019, 105 (04) : 276 - 282
  • [7] Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease
    van der Feen, Diederik E.
    Bartelds, B.
    de Boer, Rudolf A.
    Berger, Rolf M. F.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (26) : 2034 - 2040B
  • [8] The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
    Li, Gang
    Zhang, Han
    Zhao, Lei
    Zhang, Yaozhong
    Yan, Daole
    Liu, Yinglong
    Su, Junwu
    Fan, Xiangming
    [J]. PULMONARY CIRCULATION, 2019, 9 (03)
  • [9] Transgelin as a potential target in the reversibility of pulmonary arterial hypertension second to congenital heart disease
    Li Huang
    Li Li
    Tao Yang
    Wen Li
    Li Song
    Xianmin Meng
    Qing Gu
    Changming Xiong
    Jianguo He
    [J]. 中国循环杂志, 2018, (S1) : 165 - 166
  • [10] PULMONARY ARTERIAL HYPERTENSION IN CONGENITAL HEART DISEASE
    NADAS, AS
    RUDOLPH, AM
    GROSS, RE
    [J]. CIRCULATION, 1960, 22 (06) : 1041 - 1043
12345